Marc Willner

Papers

Total Citations

H-Index

About

Dr. Marc Willner is a leading expert in the safety and precision of intravenous (IV) oncology compounding, a critical area where medication errors can have severe consequences for patients. His research focuses on comparing advanced technological workflows, specifically robotics versus gravimetrics-assisted systems, to determine the most accurate and efficient methods for preparing sterile, high-risk infusions. In his most cited work (2020, 10 citations), Dr. Willner conducted a pivotal study that directly compared an IV robotic system to a gravimetric technology-assisted workflow (TAWF) platform, using the same gravimetric quality assurance system for a fair assessment. This research provides vital, evidence-based guidance for hospital pharmacies seeking to minimize human error and improve patient safety in chemotherapy preparation. By rigorously evaluating these emerging technologies, Dr. Willner’s contributions help shape best practices in pharmaceutical compounding, ensuring that oncology patients receive precisely dosed, contamination-free medications. His work is essential reading for pharmacists, healthcare administrators, and researchers dedicated to advancing the quality and safety of IV drug delivery.